North Carolina Biotechnology is categorized under Noncommercial Economic Research in Greenville, NC .
North Carolina Biotechnology was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Noncommercial Economic Research business, which does work in the B2B market, and is classified as a Noncommercial Economic Research, under code number 5417115 by the NAICS.
If you are seeking more information, feel free to contact John Chaffee at the company’s single location by writing to 2200 Charles Boulevard, Greenville, North Carolina NC 27858 or by phoning (252) 328-9981. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | North Carolina Biotechnology |
| Contact Person: | John Chaffee |
| Address: | 2200 Charles Boulevard, Greenville, North Carolina 27858 |
| Phone Number: | (252) 328-9981 |
| Website Address: | ncbiotech.org |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Economic Research |
| SIC Code: | 8733 |
| NAICS Code: | 5417115 |
| Share This Business: |
North Carolina Biotechnology was started in 0 to provide professional Noncommercial Economic Research under the SIC code 8733 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact John Chaffee for inquiries that concern North Carolina Biotechnology by calling the company number (252) 328-9981, as your correspondence is most welcome. Additionally, the physical location of the single location of North Carolina Biotechnology can be found at the coordinates 35.58571,-77.36374 as well as the street address 2200 Charles Boulevard in Greenville, North Carolina 27858.
For its online presence, you may visit North Carolina Biotechnology’s website at ncbiotech.org and engage with its social media outlets through on Twitter and on Facebook.